We report a mechanism of DTX resistance in HNSCC mediated by the secretion of IL-1β from macrophages to induce ICAM1 expression, which enhances the stemness of tumor cells and promotes PGCC formation in response to DTX treatment, thereby leading to increased chemoresistance. This evidence concerns the gene IL1B and neoplasm.